Hesham ElGhazaly, Professor of Clinical Oncology at Ain Shams University and the Founder and CEO of Alfa Cure Oncology Cente, shared a post on LinkedIn:
“Once again, I had the great pleasure of being part of the Annual Advanced International Breast Cancer Course (AIBCC), now in its 21st edition, in Padova, Italy. This meeting has truly become dear to my heart, as it consistently brings together some of the most eminent figures in the field of oncology to exchange knowledge, share expertise, and discuss the latest advancements in both early and advanced breast cancer.
What makes this course stand out is not only the cutting-edge science but also the richly interactive discussion sessions and multidisciplinary team debates, where different perspectives come together to shape the future of breast cancer care.
My sincere gratitude goes to the distinguished faculty and speakers who made this year’s program truly inspiring. Their contributions, insights, and dedication to advancing patient care created a stimulating environment of collaboration and learning that I am honored to be part of.
Looking forward to continuing these valuable exchanges and building on the spirit of science, collaboration, and innovation.”
More posts featuring Hesham ElGhazaly.
